Cargando…

Reconstructing disease dynamics for mechanistic insights and clinical benefit

Diseases change over time, both phenotypically and in their underlying molecular processes. Though understanding disease progression dynamics is critical for diagnostics and treatment, capturing these dynamics is difficult due to their complexity and the high heterogeneity in disease development bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Frishberg, Amit, Milman, Neta, Alpert, Ayelet, Spitzer, Hannah, Asani, Ben, Schiefelbein, Johannes B., Bakin, Evgeny, Regev-Berman, Karen, Priglinger, Siegfried G., Schultze, Joachim L., Theis, Fabian J., Shen-Orr, Shai S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611752/
https://www.ncbi.nlm.nih.gov/pubmed/37891175
http://dx.doi.org/10.1038/s41467-023-42354-8
_version_ 1785128551646756864
author Frishberg, Amit
Milman, Neta
Alpert, Ayelet
Spitzer, Hannah
Asani, Ben
Schiefelbein, Johannes B.
Bakin, Evgeny
Regev-Berman, Karen
Priglinger, Siegfried G.
Schultze, Joachim L.
Theis, Fabian J.
Shen-Orr, Shai S.
author_facet Frishberg, Amit
Milman, Neta
Alpert, Ayelet
Spitzer, Hannah
Asani, Ben
Schiefelbein, Johannes B.
Bakin, Evgeny
Regev-Berman, Karen
Priglinger, Siegfried G.
Schultze, Joachim L.
Theis, Fabian J.
Shen-Orr, Shai S.
author_sort Frishberg, Amit
collection PubMed
description Diseases change over time, both phenotypically and in their underlying molecular processes. Though understanding disease progression dynamics is critical for diagnostics and treatment, capturing these dynamics is difficult due to their complexity and the high heterogeneity in disease development between individuals. We present TimeAx, an algorithm which builds a comparative framework for capturing disease dynamics using high-dimensional, short time-series data. We demonstrate the utility of TimeAx by studying disease progression dynamics for multiple diseases and data types. Notably, for urothelial bladder cancer tumorigenesis, we identify a stromal pro-invasion point on the disease progression axis, characterized by massive immune cell infiltration to the tumor microenvironment and increased mortality. Moreover, the continuous TimeAx model differentiates between early and late tumors within the same tumor subtype, uncovering molecular transitions and potential targetable pathways. Overall, we present a powerful approach for studying disease progression dynamics—providing improved molecular interpretability and clinical benefits for patient stratification and outcome prediction.
format Online
Article
Text
id pubmed-10611752
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106117522023-10-29 Reconstructing disease dynamics for mechanistic insights and clinical benefit Frishberg, Amit Milman, Neta Alpert, Ayelet Spitzer, Hannah Asani, Ben Schiefelbein, Johannes B. Bakin, Evgeny Regev-Berman, Karen Priglinger, Siegfried G. Schultze, Joachim L. Theis, Fabian J. Shen-Orr, Shai S. Nat Commun Article Diseases change over time, both phenotypically and in their underlying molecular processes. Though understanding disease progression dynamics is critical for diagnostics and treatment, capturing these dynamics is difficult due to their complexity and the high heterogeneity in disease development between individuals. We present TimeAx, an algorithm which builds a comparative framework for capturing disease dynamics using high-dimensional, short time-series data. We demonstrate the utility of TimeAx by studying disease progression dynamics for multiple diseases and data types. Notably, for urothelial bladder cancer tumorigenesis, we identify a stromal pro-invasion point on the disease progression axis, characterized by massive immune cell infiltration to the tumor microenvironment and increased mortality. Moreover, the continuous TimeAx model differentiates between early and late tumors within the same tumor subtype, uncovering molecular transitions and potential targetable pathways. Overall, we present a powerful approach for studying disease progression dynamics—providing improved molecular interpretability and clinical benefits for patient stratification and outcome prediction. Nature Publishing Group UK 2023-10-27 /pmc/articles/PMC10611752/ /pubmed/37891175 http://dx.doi.org/10.1038/s41467-023-42354-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Frishberg, Amit
Milman, Neta
Alpert, Ayelet
Spitzer, Hannah
Asani, Ben
Schiefelbein, Johannes B.
Bakin, Evgeny
Regev-Berman, Karen
Priglinger, Siegfried G.
Schultze, Joachim L.
Theis, Fabian J.
Shen-Orr, Shai S.
Reconstructing disease dynamics for mechanistic insights and clinical benefit
title Reconstructing disease dynamics for mechanistic insights and clinical benefit
title_full Reconstructing disease dynamics for mechanistic insights and clinical benefit
title_fullStr Reconstructing disease dynamics for mechanistic insights and clinical benefit
title_full_unstemmed Reconstructing disease dynamics for mechanistic insights and clinical benefit
title_short Reconstructing disease dynamics for mechanistic insights and clinical benefit
title_sort reconstructing disease dynamics for mechanistic insights and clinical benefit
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611752/
https://www.ncbi.nlm.nih.gov/pubmed/37891175
http://dx.doi.org/10.1038/s41467-023-42354-8
work_keys_str_mv AT frishbergamit reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT milmanneta reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT alpertayelet reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT spitzerhannah reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT asaniben reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT schiefelbeinjohannesb reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT bakinevgeny reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT regevbermankaren reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT priglingersiegfriedg reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT schultzejoachiml reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT theisfabianj reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit
AT shenorrshais reconstructingdiseasedynamicsformechanisticinsightsandclinicalbenefit